Results 11 to 20 of about 513,834 (341)

Growth hormone deficiency during young adulthood and the benefits of growth hormone replacement

open access: yesEndocrine Connections, 2016
Until quite recently, the management of children with growth hormone deficiency (GHD) had focussed on the use of recombinant human GH (rhGH) therapy to normalise final adult height.
M Ahmid   +3 more
doaj   +2 more sources

Adult growth hormone deficiency – benefits, side effects, and risks of growth hormone replacement

open access: yesFrontiers in Endocrinology, 2013
Deficiency of growth hormone (GH) in adults results in a syndrome characterized by decreased muscle mass and exercise capacity, increased visceral fat, impaired quality of life, unfavorable alterations in lipid profile and markers of cardiovascular risk,
Mary Lim Reed   +2 more
doaj   +2 more sources

Response to growth hormone according to provocation test results in idiopathic short stature and idiopathic growth hormone deficiency [PDF]

open access: yesAnnals of Pediatric Endocrinology & Metabolism, 2022
Purpose To investigate growth response in children with either idiopathic short stature (ISS) or growth hormone (GH) deficiency (GHD). Methods The data of prepubertal GHD or ISS children treated using recombinant human GH were obtained from the LG Growth
Ju Young Yoon   +9 more
doaj   +1 more source

Actively separated microneedle patch for sustained-release of growth hormone to treat growth hormone deficiency

open access: yesActa Pharmaceutica Sinica B, 2022
Growth hormone deficiency (GHD) has become a serious healthcare burden, and presents a huge impact on the physical and mental health of patients. Here, we developed an actively separated microneedle patch (PAA/NaHCO3-Silk MN) based on silk protein for ...
Li Yang   +7 more
semanticscholar   +1 more source

Effects of adult growth hormone deficiency and replacement therapy on the cardiometabolic risk profile

open access: yesPituitary, 2022
Adult growth hormone deficiency (AGHD) is considered a rare endocrine disorder involving patients with childhood-onset and adult-onset growth hormone deficiency (AoGHD) and characterized by adverse cardiometabolic risk profile.
B. Ratku   +5 more
semanticscholar   +1 more source

Long-Acting Growth Hormone Preparations and Their Use in Children with Growth Hormone Deficiency

open access: yesHormone Research in Paediatrics, 2022
Background: Daily recombinant human growth hormone (rhGH) is approved and marketed worldwide to treat children and adults with GH deficiency and other conditions. Efficacy of rhGH therapy is influenced by several variables.
V. Pampanini   +3 more
semanticscholar   +1 more source

Growth hormone deficiency

open access: yesGüncel Pediatri, 2010
Growth hormone deficiency is the most promising entity in terms of response to therapy among the treatable causes of growth retardation. It may be due to genetic or acquired causes.
Sağlam, Halil, Tarım, Ömer
core   +2 more sources

Growth Hormone Deficiency [PDF]

open access: yesAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1987
Growth hormone deficiency is relative, not absolute. Conventional stimulation tests of hGH release do not recognise some children who will benefit from hGH treatment and it is probably justified, at this point, undertaking a six month trial of hGH in all short children who are growing slowly (less than 4 cm/yr).
openaire   +4 more sources

Adult growth hormone deficiency [PDF]

open access: yesClinical Medicine, 2003
Growth hormone deficiency (GHD) in adults arises as a consequence of decreased secretion of somatotropin (GH) from the anterior pituitary. The diagnosis of GHD is dependent on the demonstration of a subnormal rise in serum GH in response to one or more dynamic stimulation tests in the presence of co-existing pituitary disease or other pituitary hormone
A M, Brooke, J P, Monson
openaire   +2 more sources

Prolyl Endopeptidase-like Deficiency Associated with Growth Hormone Deficiency

open access: yesJCRPE, 2023
Prolyl endopeptidase-like (PREPL) deficiency (MIM#616224) is a rare congenital disorder characterised by neonatal hypotonia and feeding difficulties, growth hormone (GH) deficiency and hypergonadotropic hypogonadism.
Laura Sayol-Torres   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy